JPWO2023238881A1 - - Google Patents
Info
- Publication number
- JPWO2023238881A1 JPWO2023238881A1 JP2024526994A JP2024526994A JPWO2023238881A1 JP WO2023238881 A1 JPWO2023238881 A1 JP WO2023238881A1 JP 2024526994 A JP2024526994 A JP 2024526994A JP 2024526994 A JP2024526994 A JP 2024526994A JP WO2023238881 A1 JPWO2023238881 A1 JP WO2023238881A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96466—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022092192 | 2022-06-07 | ||
| PCT/JP2023/021092 WO2023238881A1 (ja) | 2022-06-07 | 2023-06-07 | 非アルコール性脂肪性肝疾患（ｎａｆｌｄ）または非アルコール性脂肪肝炎（ｎａｓｈ）を診断するためのマーカー |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023238881A1 true JPWO2023238881A1 (https=) | 2023-12-14 |
Family
ID=89118332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526994A Pending JPWO2023238881A1 (https=) | 2022-06-07 | 2023-06-07 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4553503A1 (https=) |
| JP (1) | JPWO2023238881A1 (https=) |
| CN (1) | CN119343602A (https=) |
| WO (1) | WO2023238881A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3273247A1 (en) * | 2010-06-10 | 2018-01-24 | Metanomics Health GmbH | Methods for the diagnosis of liver diseases |
| US20170370954A1 (en) * | 2014-11-19 | 2017-12-28 | Metabolon, Inc. | Biomarkers for Fatty Liver Disease and Methods Using the Same |
| CN108130370B (zh) * | 2018-01-05 | 2020-11-17 | 武汉惠康达科技有限公司 | Psmb8及其抑制剂在制备治疗脂肪肝及其相关疾病药物中的应用 |
| KR20220140727A (ko) * | 2020-02-10 | 2022-10-18 | 소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 | 비알코올성 지방간염 (nash) 바이오마커 및 이의 용도 |
-
2023
- 2023-06-07 WO PCT/JP2023/021092 patent/WO2023238881A1/ja not_active Ceased
- 2023-06-07 EP EP23819861.8A patent/EP4553503A1/en active Pending
- 2023-06-07 JP JP2024526994A patent/JPWO2023238881A1/ja active Pending
- 2023-06-07 CN CN202380045370.4A patent/CN119343602A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN119343602A (zh) | 2025-01-21 |
| WO2023238881A1 (ja) | 2023-12-14 |
| EP4553503A1 (en) | 2025-05-14 |